SMID Biotech Access Fund LP — Form D

SMID Biotech Access Fund LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2026-01-29. $250K was reported sold. Industry: Other.

Offering

• Filed: 2026-01-29
• Form: D
• Accession: 0002107868-26-000001
• Industry: Other
• Exemptions: 06c
• Amount sold: $250K
• Minimum investment: $50K
• Investors: 4
• Date of first sale: 2026-01-13
• Security types: fund interests
• Revenue range: Decline to Disclose
• SEC file number: 021-571604

Issuer

• Name: SMID Biotech Access Fund LP
• CIK: 0002107868
• Entity type: Limited Partnership
• Jurisdiction: DELAWARE
• Incorporated: 2025
• Address: 1325 AVENUE OF THE AMERICAS, NEW YORK, NY, 10019
• Phone: 5162814242

Officers, directors & promoters (1)

More

• CIK 2107868 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search